涂召旭(副研究员,博士生导师)

涂召旭,中山大学“百人计划”特聘副研究员,博士生导师,德国柏林自由大学博士(优等博士学位,top 1%),美国哥伦比亚大学博士后。
主要研究方向为“上气道炎症机制及靶向治疗”,目前发表高水平论文30余篇,单篇最高影响因子87.6,论文累计应用次数约4000次。其中第一及通讯作者发表杂志包括Nat. Rev. Mat. (中科院1区,IF=87.6), Nat. Comm.(中科院1区,IF=15.5),Adv. Mat.(中科院1区,IF=32.8), Exploration (中科院1区,IF=22.5),Adv. Funct. Mat.(中科院1区,IF=19.0), ACS NANO(中科院1区,IF=15.8),Adv. Sci.(中科院1区,IF=14.1)等.同时获授权中国发明专利12项,多次受邀在国际学术会议做口头报告,


教育背景:
(1) 2014-09 至 2018-07, 德国,柏林自由大学,博士
(2) 2011-09 至 2014-06, 中国,四川大学,硕士
(3) 2007-09 至 2011-06, 中国,四川大学,学士 


科研工作经历:
(1)2021-11 至 今, 中山大学, 附属第六医院, 副研究员/博士生导师
(2) 2018-11 至 2021-10, 美国,哥伦比亚大学
(3) 2018-08 至 2018-10, 德国,柏林自由大学


团队研究方向:
1.上气道难治性炎症疾病的炎症机制;
2.上气道炎症疾病的纳米靶向治疗技术。

代表性论文代表性项目荣誉

10篇代表性论文(第一/通讯作者):
(1) Ming Liu, Changyi Xu, Renqiang Ma, Xinran Xie, YingXie, Mengya Du, Zhaofeng Xu, Shuaiyin Zhang, Jian Li, Weiping Wen, Zhaoxu Tu*, Surmounting Recalcitrant Airway Inflammatory Disorders With a Multi-Targeting Therapeutic Strategy by Tannic Acid-Modified CuInP2S6 Nanosheets, Exploration 2026,(中科院一区,影响因子:22.5)
(2) Yuefei Zhu, Changyi Xu, Zhixin Li, Xiaomin Bao, Ming Liu, Yangyang She, Renqiang Ma, Xiangzhen Liu, Jian Li, Weiping Wen*, Kam W. Leong*, Zhaoxu Tu*, Nanostructured organic sheets sequestering small extracellular vesicles and reactive species to protect against radiation-induced mucositis, Nature Communications 2025, 16, 6120 (中科院一区,影响因子:15.7)
(3) Zhaoxu Tu* Junyan Lin, Zhixin Li, Yuefei Zhu, Changyi Xu, Zihan Qiu, Qiumin Wang, Yang Ye, Yihui Wen,* Jian Li,* Kam W. Leong, and Weiping Wen*, Tackling Allergic Airway Inflammation with Organic Sheet-Like Nanoplatforms by Targeted Elimination of Epithelial Small Extracellular Vesicles, Adv. Sci.  2025, 12,(中科院一区,影响因子:15.1)
(4) Changyi Xu, Ming Liu, Xinran Xie, Zhixin Li, Yuefei Zhu, Yang Ye, Mengya Du, Suhua Hu, Tianrun Liu, Yubiao Guo, Weiping Wen, Huanliang Liu, and Zhaoxu Tu*, Multifunctional Boron-based 2D Nanoplatforms Ameliorate Severe Respiratory Inflammation by Targeting Multiple Inflammatory Mediators, Adv. Sci. 2025, 12,(中科院一区,影响因子:15.1)
(5) Zhaoxu Tu*, M. Liu, C. Xu, Y. Wei, T. Lu, Y. Xiao, H. Li, S. Zhang, X. Xie, Jian Li*, Weiping Wen*, Functional 2D nanoplatforms alleviate eosinophilic chronic rhinosinusitis by modulating eosinophil extracellular trap formation, Adv. Sci. 2024, 11, (中科院1区,影响因子:15.1)
(6) Zhaoxu Tu*, Y. Zhu, W. Gao, M. Liu, Y. Wei, C. Xu, Y. Xiao, Y. Wen, J. Li, Kam W. Leong*, and Weiping Wen*, Tackling Severe Neutrophilic Inflammation in Airway Disorders with Functionalized Nanosheets, ACS NANO 2024, 18, 7084. (中科院1区,影响因子:17.1)
(7) Zhaoxu Tu; Yiling Zhong; Hanze Hu; Dan Shao; Rainer Haag; Michael Schirner; Jaewoo Lee; B ruce Sullenger; Kam W. Leong ; Design of therapeutic biomaterials to control inflammation, Nature Review Materials, 2022,7, 557-574(中科院1区,影响因子:83.5)
(8) Yongqiang Xiao, Xinyue Wang, Ming Liu, Xiao Fu, Nanfeng Zhang, Wenqing Yang, Junyi Ge, Yangyang Li, Duan Ma, Jing Ma, Weiping Wen, Dongdong Ren*, Tianyu Zhang*, and Zhaoxu Tu*, Targeting Neutrophil/Eosinophil Extracellular Traps by Aptamer-Functionalized Nanosheets to Overcome Recalcitrant Inflammatory Disorders, Adv. Sci. 2025, 12,(中科院一区,影响因子:15.1)
(9) Changhui Chen, Hang Li, Yilin Hou, Yihui Wen, Jian Li, Hua Zhong, Tong Lu, Zhengqi Li, Lin Sun, Shimin Lai, Yan Yan, Jieying Yan, Zihan Qiu, Nan Zhang, Claus Bachert, Zhaoxu Tu*, Weiping Wen*, Yi Wei*, Prognostic Significance of Eosinophil Extracellular Traps in Chronic Rhinosinusitis and Innovative Nanosheets-Based Clearance Therapy, Clinical & Experimental Allergy 2026 (中科院二区,影响因子:6.1)
(10) Yongqiang Xiao, He Fang, Xin Wang, Ming Liu, Tuo Shen, Mei Zhang, Zhaofan Xia, Kam W. Leong, Duan Ma, Jing Ma*, Zhaoxu Tu*, Tianyu Zhang*, Modulation of Unregulated Inflammation-Associated Coagulopathy in Sepsis Using Multifunctional Nanosheets, Adv. Funct. Mater. 2024, 34, 2402785. (中科院一区,影响因子:19.9)